Reply to: “Community health strategies for chronic hepatitis B: Advancing care with the ALT/qHBsAg ratio”,Journal of Hepatology

当前位置： X-MOL 学术 › J. Hepatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Reply to: “Community health strategies for chronic hepatitis B: Advancing care with the ALT/qHBsAg ratio”
Journal of Hepatology ( IF 26.8 ) Pub Date : 2024-11-06 , DOI: 10.1016/j.jhep.2024.10.042
Rex Wan-Hin Hui, Lung-Yi Mak, Man-Fung Yuen

Section snippets

Author Contributions

RWH Hui was involved in manuscript design and drafting of manuscript. LY Mak was involved in critical revision of manuscript. MF Yuen was involved in critical revision of manuscript and overall study supervision. The authors declare that they have participated in the preparation of the manuscript and have seen and approved the final version.

Disclosures/ Conflict Of Interest Statement

MF Yuen is an advisory board member and/or received research funding from AbbVie, Arbutus Biopharma, Assembly Biosciences, Bristol Myer Squibb, Dicerna Pharmaceuticals, GlaxoSmithKline, Gilead Sciences, Janssen, Merck Sharp and Dohme, Clear B Therapeutics, Springbank Pharmaceuticals; and received research funding from Arrowhead Pharmaceuticals, Fujirebio Incorporation and Sysmex Corporation. The remaining authors have no conflict of interests.

Data Availability Statement

The data from this study is available from the corresponding author upon reasonable request.

Funding

Innovative Research Fund of the State Key Laboratory of Liver Research, The University of Hong Kong (ref. no.: SKLLR/IRF/2018/07) and the S. K. Yee Medical Foundation Grant (ref. no.: 2141213). The funders had no involvement in study design, data collection/ analysis/ interpretation, writing of the manuscript or decision to submit the article for publication.

更新日期：2024-11-06

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南